Overview of Dr. Shah
Dr. Shilpan Shah is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital, Houston Methodist Sugar Land Hospital, Houston Methodist Willowbrook Hospital, Houston Methodist Baytown Hospital, Houston Methodist West Hospital, Houston Methodist The Woodlands Hospital, Houston Methodist Clear Lake Hospital, and Memorial Hermann - Texas Medical Center. He received his medical degree from Baroda Medical College and has been in practice 15 years. He is one of 90 doctors at Houston Methodist Hospital and one of 29 doctors at Memorial Hermann - Texas Medical Center who specialize in Oncology. He has more than 10 publications and over 200 citings.
Office
6445 Main Street
OPC 24
Houston, TX 77030Fax+1 713-441-8791
Education & Training
- University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2013 - 2014
- Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
- Stony Brook Medicine/University HospitalChief Residency, Internal Medicine, 2009 - 2010
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2006 - 2009
- Baroda Medical CollegeClass of 2002
Certifications & Licensure
- TX State Medical License 2012 - 2026
- NY State Medical License 2009 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsTreatment of primary cardiac diffuse large B-cell lymphoma involving the coronary sinus with R-EPOCH: a case report and literature review.Aryan Rezvani, Shilpan Shah
Annals of Hematology. 2024-07-01 - Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.Ethan A Burns, Justin J Wilson, Sunil Mathur, Ryan Kieser, Zimu Gong
Annals of Hematology. 2023-10-01 - 3 citationsCell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia.Jianming Shao, Shilpan Shah, Siddhartha Ganguly, Youli Zu, Chuan He
Clinical Epigenetics. 2023-08-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: